Financing channel feed

A once-pub­lic psy­che­del­ic biotech reemerges with $103M from MPM and No­vo Hold­ings

Last year
Startups

Ex­clu­sive: Spark co-founder launch­es new CNS gene ther­a­py biotech with $54M

Last year
Startups
Cell/Gene Tx

Ex­clu­sive: Pic­tion Health rais­es $6M to cut wait times for skin con­di­tions

Last year
Health Tech

In one of JP Mor­gan's first biotech bets, En­laza rais­es $100M for its per­ma­nent­ly bind­ing pro­tein drugs

Last year

Cidara buys back flu rights, sells an­ti­fun­gal and inks $240M PIPE

Last year
Deals
Pharma

En­deav­or Bio­Med­i­cines snags $132M for Phase 2 fi­bro­sis drug, ADC can­di­date

Last year
Startups

Dutch biotech at­tracts J&J sup­port for can­cer pipeline in $21M Se­ries A

Last year
R&D

Re­gen­eron’s $500M fund spot­lights cor­po­rate ven­ture’s in­flu­en­tial role in biotech

Last year
Startups
Pharma

Rube­do pulls in $40M Se­ries A to ad­vance atopic der­mati­tis can­di­date tar­get­ing ag­ing cells

Last year

Irish biotech col­lects $75M in Se­ries B to start Phase 3 rare joint tu­mor tri­al

Last year

Cor­ner Ther­a­peu­tics to hy­per­ac­ti­vate ‘the brains of the im­mune sys­tem’ with $54M launch

Last year
Startups

Bris­tol My­ers pitch­es in to Pathios’ $25M Se­ries B for GPCR in­hibitor

Last year
R&D

ARCH-backed start­up Met­sera launch­es with $290M to take on obe­si­ty gi­ants

Last year

Canaan adds $100M+ to boost bio­phar­ma in­vest­ing, brings on for­mer Pfiz­er ex­ec

Last year
People

In lat­est turn to au­toim­mune ther­a­pies, Cul­li­nan nabs $280M to join lu­pus space

Last year
R&D

Ex­clu­sive: Eat­ing dis­or­der tele­health start­up Equip rais­es $35M, ac­cord­ing to fil­ing

Last year
Health Tech

Re­gen­eron en­ters ven­ture in­vest­ing with $500M, poach­es se­nior part­ner from ARCH

Last year
People

Obe­si­ty drug­mak­er lands first bio­phar­ma up­list­ing on­to Nas­daq since last sum­mer

Last year
Startups

In­vestors aren't back­ing fer­til­i­ty star­tups like they used to — part of dig­i­tal health's re­set

Last year
Health Tech

An­oth­er ADC biotech reels in big bucks as Mark Alles’ TORL nabs $158M

Last year
Startups

Big come­back? The Q1 re­port on biotech is in, and there’s been some sput­ter­ing

Last year
Deals
Bioregnum

Up­dat­ed: Steve Paul, Daphne Zo­har re­unite for an­oth­er neu­ro start­up af­ter Karuna suc­cess

Last year
People
Startups

Two ex-blue­bird lead­ers launch Nvel­op with $100M to tack­le the biggest prob­lem in gene edit­ing

Last year

Health tech star­tups raised $2.7B last quar­ter. It's the low­est Q1 to­tal in five years

Last year
Health Tech
First page Previous page 15161718192021 Next page Last page
A service from the Financial Times